Antagonists of microRNA-29 for use in the prevention and treatment of aortic aneurysms
The present invention relates to the use of antagonists of the miR-29 family to prevent and/or treat aortic aneurysms and rupture of atherosclerotic plaques.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Laser immersion probe for smart inline monitoring of water and wastewater
A new type of laser-based immersion probe, which the Fraunhofer Institute for Laser Technology ILT in Aachen is testing as part of BMBF- and EU-funded projects with industrial partners and…
Webb captures top of iconic horsehead nebula in unprecedented detail
NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
